The most common side effects of irbesartan are headache, dizziness, and fatigue. In clinical trials involving nearly 1,800 patients, about 7.7% experienced side effects within 24 hours of their first dose, and these three symptoms accounted for the majority. Most people tolerate irbesartan well, and serious reactions are uncommon.
The Most Frequent Side Effects
In a large study of older adults with mild-to-moderate high blood pressure, headache was the single most reported side effect at 12.9%, followed by dizziness at 4.3% and joint pain at 2.9%. Broader clinical trial data also lists stomach discomfort, muscle pain, and flu-like symptoms among the more commonly reported issues, with rates generally falling between 2% and 5%.
A head-to-head trial comparing irbesartan to three other medications in the same drug class found that about 35.6% of irbesartan users reported at least one side effect of any kind. That sounds high, but the numbers were similar across all four drugs tested, and most of the reported events were mild. The specific breakdown for irbesartan users: headache in 5.5%, upper respiratory infections in 5.5%, dizziness in 3.4%, diarrhea in 3.4%, flu-like symptoms in 2.7%, and fatigue in 1.4%. Only one patient out of 146 on irbesartan dropped out of that trial because of side effects.
Why Irbesartan Causes Dizziness
Irbesartan works by blocking a hormone that tightens blood vessels. When that hormone is blocked, your blood vessels relax and your blood pressure drops. The dizziness and lightheadedness people feel, especially early on, come from this pressure drop. It’s most noticeable when you stand up quickly from sitting or lying down, because gravity pulls blood toward your legs and the medication makes it harder for your body to compensate.
If you notice dizziness, lying down for a moment can help prevent fainting. Then sit for a few minutes before standing again. It’s worth testing how the medication affects you before driving or operating machinery, particularly in the first few days.
Higher Doses Mean More Side Effects
A study comparing the 150 mg and 300 mg doses found a clear difference in dizziness: 10.4% of patients on the higher dose experienced it, compared to 3.2% on the lower dose. All seven serious adverse events in that trial occurred in the 300 mg group. Swelling in the lower legs, while uncommon, also showed up more often at the higher dose. Hyperkalemia (elevated potassium levels) appeared only in the 300 mg group, though the numbers were small.
This dose-dependent pattern is one reason doctors typically start at a lower dose and increase it only if blood pressure isn’t adequately controlled.
Serious but Rare Reactions
Most side effects from irbesartan are mild and manageable, but a few serious reactions can occur.
Kidney problems are the most significant concern. Irbesartan changes blood flow within the kidneys as part of how it lowers blood pressure. For most people this is harmless or even protective, but in patients whose kidneys already depend heavily on the hormone irbesartan blocks, kidney function can decline. People who are dehydrated, taking diuretics, or already have kidney disease face higher risk. Elevated creatinine in blood tests, a marker of kidney strain, is the most common lab abnormality seen with the drug. That said, a study specifically enrolling patients with existing kidney impairment found irbesartan was well tolerated in that group, with only one out of 52 patients needing to stop due to high potassium.
High potassium is another concern worth knowing about. Irbesartan reduces the body’s ability to excrete potassium through the kidneys. In clinical trials, hyperkalemia occurred in fewer than 1% of patients, but the risk rises if you’re also taking potassium supplements, potassium-sparing diuretics, or common pain relievers like ibuprofen or naproxen.
Angioedema, a sudden swelling of the face, lips, throat, or tongue, has been reported after the drug reached the market. It’s rare but requires immediate medical attention because it can obstruct breathing.
How It Compares to Similar Medications
Irbesartan belongs to a class of drugs called angiotensin receptor blockers, or ARBs, which includes losartan, valsartan, and olmesartan. All of them share the same basic mechanism and a similar side effect profile. In the head-to-head trial, the overall rate of adverse events for irbesartan (35.6%) was slightly higher than olmesartan (30.6%) and losartan (32.0%) but lower than valsartan (44.8%). These differences were modest and may reflect normal variation rather than meaningful gaps between the drugs.
Where irbesartan stood out positively was in lab abnormalities. Only 2.1% of irbesartan users had laboratory-related adverse events, the lowest rate among all four drugs tested. The class as a whole is known for producing fewer side effects than older blood pressure medications, particularly the dry cough that’s common with ACE inhibitors. Cough was reported by less than 1% of irbesartan users in trial data.
Who Should Be More Cautious
Certain groups face a higher chance of side effects. Older adults and anyone who is volume-depleted (from not drinking enough fluids, from diarrhea, or from taking water pills) are more susceptible to the blood pressure dropping too far. If you take nonsteroidal anti-inflammatory drugs like ibuprofen regularly alongside irbesartan, your risk of kidney problems increases.
Irbesartan is not safe during pregnancy. Drugs in this class can cause severe harm to a developing fetus, including kidney failure and skull abnormalities. Women who become pregnant while taking irbesartan should contact their doctor promptly about switching to a different medication.